RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

STMN.CH

88.72

+0.91%↑

BANB.CH

58.9

+0.86%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

STMN.CH

88.72

+0.91%↑

BANB.CH

58.9

+0.86%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

STMN.CH

88.72

+0.91%↑

BANB.CH

58.9

+0.86%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

STMN.CH

88.72

+0.91%↑

BANB.CH

58.9

+0.86%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

STMN.CH

88.72

+0.91%↑

BANB.CH

58.9

+0.86%↑

Search

Sandoz Group AG

Închisă

46.38 1.49

Rezumat

Modificarea prețului

24h

Curent

Minim

45.17

Maxim

46.6

Indicatori cheie

By Trading Economics

Venit

526M

377M

Vânzări

1.2B

5.3B

P/E

Medie Sector

114.146

35.739

EPS

0.87

Randament dividend

1.39

Marjă de profit

7.16

Angajați

20,000

EBITDA

475M

602M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+11.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.39%

3.08%

Următoarele câștiguri

30 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-659M

20B

Deschiderea anterioară

44.89

Închiderea anterioară

46.38

Sandoz Group AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 iul. 2025, 10:51 UTC

Market Talk

U.S.-EU Tariff Deal, Earnings Could Keep Pharma Rally Going -- Market Talk

15 apr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

17 dec. 2024, 07:45 UTC

Market Talk

Sandoz's U.S. Settlement to Cost 1.1 Swiss Francs a Share -- Market Talk

17 dec. 2024, 07:34 UTC

Market Talk

Sandoz's U.S. Settlement Shows Commitment Move Forward -- Market Talk

10 dec. 2024, 07:05 UTC

Market Talk

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Comparație

Modificare preț

Sandoz Group AG Așteptări

Obiectiv de preț

By TipRanks

11.6% sus

Prognoză pe 12 luni

Medie 49.898 CHF  11.6%

Maxim 55 CHF

Minim 42.6 CHF

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSandoz Group AG - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

5

Cumpărare

3

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
help-icon Live chat